Grant: Engage Grants Program
University of British Columbia
$25,000.00
Fabrication and testing of a real-time nicotine detector for digital health management
FY 2019-20
Summary
Chronic obstructive pulmonary disease (COPD) is the leading cause of hospital admissions among major chronic illnesses in Canada and costs taxpayers roughly $1.5 billion each year. Although there are no cures for COPD, effective management of the disease through early detection and continuous monitoring has been shown to reduce costs and improve patient outcomes. Agartee Technology Inc. is a Canadian digital healthcare start-up that has developed a novel health tracking platform to actively monitor key indicators of COPD using proprietary sensors. The platform then relays this information to healthcare providers in real-time, thereby allowing them to make informed decisions to improve the patient's quality of life. The current collaborative project between the University of British Columbia and Agartee aims to extend the capabilities of the platform to also detecting nicotine in the ambient air. Nicotine in second-hand smoke can greatly exacerbate COPD and augmenting the current platform with a nicotine sensor and alerting system could further improve the quality of management of the disease. The nicotine sensor and alerting system would be constructed using novel and robust yet cheap conducting polymer films and electronic components and will seamlessly integrate with Agartee's current platform. The construction of low-cost and durable health monitoring systems of the type that we are proposing will prove to be game-changers for the healthcare system.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
542826-2019
Name nom
Yadav, VikramadityaGanapati
Department département
Chemical and Biological Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Fabrication and testing of a real-time nicotine detector for digital health management
Keyword
NSERC
Application summary
Chronic obstructive pulmonary disease (COPD) is the leading cause of hospital admissions among major chronic illnesses in Canada and costs taxpayers roughly $1.5 billion each year. Although there are no cures for COPD, effective management of the disease through early detection and continuous monitoring has been shown to reduce costs and improve patient outcomes. Agartee Technology Inc. is a Canadian digital healthcare start-up that has developed a novel health tracking platform to actively monitor key indicators of COPD using proprietary sensors. The platform then relays this information to healthcare providers in real-time, thereby allowing them to make informed decisions to improve the patient's quality of life. The current collaborative project between the University of British Columbia and Agartee aims to extend the capabilities of the platform to also detecting nicotine in the ambient air. Nicotine in second-hand smoke can greatly exacerbate COPD and augmenting the current platform with a nicotine sensor and alerting system could further improve the quality of management of the disease. The nicotine sensor and alerting system would be constructed using novel and robust yet cheap conducting polymer films and electronic components and will seamlessly integrate with Agartee's current platform. The construction of low-cost and durable health monitoring systems of the type that we are proposing will prove to be game-changers for the healthcare system.